Summer Sale - Claim 70% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
The latest update is out from Osteopore Ltd. ( (AU:OSX) ).
Osteopore Limited has appointed Pitcher Partners BA&A Pty Ltd as its new external auditor, effective 31 July 2026, following the resignation of Grant Thornton Audit Pty Ltd and approval of the change by ASIC under the Corporations Act. The board selected Pitcher Partners based on its reputation, experience and competitive fee structure, and will seek shareholder approval to confirm the appointment at the next annual general meeting, signalling a move the company says is in the best interests of shareholders and corporate governance.
The auditor transition underscores Osteopore’s focus on strengthening its financial oversight as it advances its regenerative medicine business and maintains compliance with ASX and statutory requirements. For investors and other stakeholders, the change suggests an emphasis on audit quality and cost efficiency, which may support confidence in the company’s reporting and governance framework.
More about Osteopore Ltd.
Osteopore Limited is an Australian-Singaporean regenerative medicine company listed on the ASX, focused on developing and commercialising medical technologies for tissue regeneration. The company operates in the healthcare sector, targeting clinical applications where regenerative solutions can improve patient outcomes and support long-term growth in advanced medical treatments.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$3.12M
Find detailed analytics on OSX stock on TipRanks’ Stock Analysis page.